SPARCL1 and neoplasm: The eight candidate genes—CD72, CHRDL2, DBI, HYAL1, IGFBP3, LRP11, SERPINH1, and SPARCL1—are involved in regulating the tumor immune microenvironment in CRC by modulating various immune cell types.